|(eMail): MN1.com Press Conference for GenoMed |
ST. LOUIS, MO, Jun 29, 2006 – GenoMed, Inc. (PINKSHEETS: GMED) will conduct a live press conference on www.MN1.com at 9:30am Central Time Friday, June 30th, 2006. Interested parties may go to www.MN1.com and download the free player enabling them to listen in for management's review of operations and discussion of future prospects. This live broadcast is available to anyone at any computer connected to the Internet. This should prove to be an eye-opening and enriching experience for all of those associated with GenoMed (PINKSHEETS: GMED).
MN1.com is the only online destination that brings real microcap news to investors and features live interaction with companies from the Bulletin Board, Pink Sheets, and Amex. Featuring Live Press Conferences, All-Day Live Trading Commentary, Analyst Profiles, Interactive Forums, News Items, and "The MicroBlog," MN1.com gives microcap investors the information source necessary to trade in the markets. MN1.com boasts being the largest true news company reporting on microcap traded stocks.
GenoMed (PINKSHEETS: GMED) is a St. Louis-based Next Generation Disease Management company that uses genomics to improve patient outcomes. Besides kidney disease, GenoMed has novel approaches to many additional diseases, including a general viral antidote. Anyone can download GenoMed's protocol for avian influenza or West Nile virus from GenoMed's website, www.genomed.com, at any time of day or night.
CONTACT: David Moskowitz MD